Advanced Search
ZOU Bing-xin, HUANG Zuo-ping, XIE Qiang, ZHAO Dang, WANG Li-geng. The Analysis of Clinic Effects and Quality of Life in the Treatment for Moderate to Sever Cancer Pain[J]. Cancer Research on Prevention and Treatment, 2007, 34(03): 207-208. DOI: 10.3971/j.issn.1000-8578.1533
Citation: ZOU Bing-xin, HUANG Zuo-ping, XIE Qiang, ZHAO Dang, WANG Li-geng. The Analysis of Clinic Effects and Quality of Life in the Treatment for Moderate to Sever Cancer Pain[J]. Cancer Research on Prevention and Treatment, 2007, 34(03): 207-208. DOI: 10.3971/j.issn.1000-8578.1533
shu

The Analysis of Clinic Effects and Quality of Life in the Treatment for Moderate to Sever Cancer Pain

  • The Third Department of Internal Medicine, Guang dong Provincial Corp Hospital of Chinese Peoples Armed Police Force, Guangzhou 510507, China

More Information
  • Corresponding author:

    ZOU Bing-xin

  • Received Date: March 06, 2006
  • Revised Date: October 09, 2006
    Abstract
  • Objective 　To investigate the efficacy, side effects and quality of life between transdermal fentanyl plaster (Durogesic) and sustained release morphine tablet (MS-Contin) in the treatment for moderate to sever cancer pain. Methods 　126 patients were randomized into Durogesic group (group A) and MS-Contin group (group B) . The two groups received Durogesic and MS-contin respectively. Then the efficacy, side effects and quality of life were recorded. Results 　The difference of the effective rates and quality of life of Durogesic and MS-Contin were not significant . However, the incidence of vomit and constipation were significantly higher in the MS-Contin group than that of in the Durogesic group . Conclusion 　The Durogesic is a drug that is safe, reliable and has little side effect in treating moderate to sever cancer pain.
    • FullText(HTML)
    • References (0)
    • Related Articles

  • Related Articles

    [1]CHEN Yajun, LI Chunlei, ZENG Yaqi, DONG Jie, LI Yueying, ZHANG Ping, WANG Kun. Correlation Between Nutritional Status and Serum C-reactive Protein in Patients with Cancer Pain[J]. Cancer Research on Prevention and Treatment, 2020, 47(5): 372-375. DOI: 10.3971/j.issn.1000-8578.2020.19.1250
    [2]WAN Fusu, DONG Shuang, CAI Qian, HU Sheng, FENG Gang. A Comparison Study Between Low-dose Oxycodone/Acetaminophen Tablet and Codeine on Moderate Bone Metastasis Cancer Pain[J]. Cancer Research on Prevention and Treatment, 2019, 46(7): 632-634. DOI: 10.3971/j.issn.1000-8578.2019.18.1924
    [3]WU Linxin, SUN Li. Status and Relevant Causes of Cancer Pain Undertreatment[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 421-424. DOI: 10.3971/j.issn.1000-8578.2014.04.031
    [4]Chen Liming, Li Xiaojie, Xie Xiaoyuan, Chen Jinuan. Clinical Observation of Continuous Intravenous Morphine Pumping in Patients with Refractory Cancer Pain[J]. Cancer Research on Prevention and Treatment, 2012, 39(08): 1014-1016. DOI: 10.3971/j.issn.1000-8578.2012.08.032
    [5]YAN Peng, CHEN Yuan. Analgesic Effects of Compound Capsule of Oxycodone with Acetaminophen and MS Contin Controlled-release Tab on Moderate and Severe Cancer Pains[J]. Cancer Research on Prevention and Treatment, 2011, 38(03): 324-325. DOI: 10.3971/j.issn.1000-8578.2011.03.023
    [6]HU Qing, QIU Hong, MEI Ni, RAN Feng-ming, ZANG Ai-hua. Survey of Cancer Pain and Its Treatment[J]. Cancer Research on Prevention and Treatment, 2010, 37(12): 1433-1435. DOI: 10.3971/j.issn.1000-8578.2010.12.027
    [7]HUAN G Peiqiang, FEN G Gang, ZHANG Lijuan. Comparison of Morphine Sustained Release Tablets between Rectal Administration and O2 ral Administration in Treatment of Cancer Pain[J]. Cancer Research on Prevention and Treatment, 2008, 35(S1): 26-27. DOI: 10.3971/j.issn.1000-8578.982
    [8]XU Jian-fang, CHEN Yan. Observation on the Eff icacy of Durogesic in Treatment of Sixty Patients with Moderate or Severe Pain[J]. Cancer Research on Prevention and Treatment, 2007, 34(06): 457-458. DOI: 10.3971/j.issn.1000-8578.579
    [9]DING Jian, ZHUANG Jian-sheng, LIN Xin-min, et al, . Durogesic in 42 patients with moderate or severe cancer pain[J]. Cancer Research on Prevention and Treatment, 2003, 30(05): 411-412. DOI: 10.3971/j.issn.1000-8578.2111
    [10]Ding Yongwei, . Analgesic effect of Irsinipinum in cancer pain[J]. Cancer Research on Prevention and Treatment, 1995, 22(1): 28-30.

Catalog

    WANG Li-geng

    • The Third Department of Internal Medicine, Guang dong Provincial Corp Hospital of Chinese Peoples Armed Police Force, Guangzhou 510507, China

    1. On this Site
    2. On Google Scholar
    3. On PubMed
    Get Citation
    PDF
    XML
    Article views (3042) PDF downloads (838) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    Related Articles

    Contact Us

    Address：116 Zhuodaoquan South Road,
    Hongshan District, Wuhan（430079）

    Tel：027－87670126

    Email：zlfzyjzz@vip.163.com

    This work is licensed under a Creative Commons Attribution 3.0 License.

    Email Alert RSS
    Total visits：24639325 Visits today：24537

    Copyright © Editorial Department of Cancer Prevention Research 鄂公网安备 42011102005013号 鄂ICP备2022015867号

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return